Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA

Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA

Submitted by admin on June 27, 2022 - 10:12am
Source: 
Motley Fool
News Tags: 
Sanofi
Regeneron
FDA
Dupixent
eosinophilic esophagitis
Headline: 
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
snippet: 
  • Dupixent now has access to a market of tens of thousands of patients.
  • It could bring nearly $900 million in annual sales for Sanofi and Regeneron to split.
  • Sanofi looks like a reasonably priced stock for its growth prospects.

Do Not Allow Advertisers to Use My Personal information